Similar articles

• Evaluation of merocyanine 540-sensitized photoirradiation as a means to inactivate enveloped viruses in blood products.

  O'Brien JM, Montgomery RR, Burns WH, Gaffney DK, Sieber F. O'Brien JM, et al. J Lab Clin Med. 1990 Oct;116(4):439-47. J Lab Clin Med. 1990. PMID: 2170551
• Preactivated merocyanine 540 inactivates HIV-1 and SIV: potential therapeutic and blood banking applications.

  Tran CC, Allan JS, Pervaiz S, Matthews JL, Trevino SR, Gulliya KS. Tran CC, et al. J Acquir Immune Defic Syndr (1988). 1992;5(2):188-95. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1732511
• Structure-activity relationships in the antiviral and antileukemic photoproperties of merocyanine dyes.

  Günther WH, Searle R, Sieber F. Günther WH, et al. Semin Hematol. 1992 Apr;29(2):88-94. Semin Hematol. 1992. PMID: 1594949 No abstract available.
• Merocyanine-sensitized photoinactivation of enveloped viruses.

  Sieber F, O'Brien JM, Gaffney DK. Sieber F, et al. Blood Cells. 1992;18(1):117-27; discussion 128. Blood Cells. 1992. PMID: 1617187 Review.
• Phototherapy, photochemotherapy, and bone marrow transplantation.

  Sieber F. Sieber F. J Hematother. 1993 Spring;2(1):43-62. doi: 10.1089/scd.1.1993.2.43. J Hematother. 1993. PMID: 7921966 Review.